Adjuvant and Neoadjuvant Therapy, Treatment for Advanced Disease, and Genetic Considerations for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group

Dr. Rick Greene and Dr. Paxton Dickson discuss adrenocortical carcinoma and related issues regarding adjuvant and neoadjuvant therapy, treatment of advanced disease, and genetic considerations for patients who have this disease. Dr. Dickson is author of, “Adjuvant and Neoadjuvant Therapy, Treatment for Advanced Disease, and Genetic Considerations for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group.” Dr. Dickson currently serves as an associate professor of surgery at the University of Tennessee Health Science Center and a surgical oncologist for UT Methodist Physicians. His clinical focus is in the treatment of patients with hepatobiliary, pancreatic, gastric and endocrine tumors and disease processes.